Anika Therapeutics (ANIK) Tax Rate Growth (3y) (2013 - 2026)
Anika Therapeutics (ANIK) Tax Rate Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn |
| 10 | Anika Therapeutics | 203.10 Mn | 136.31 Mn | 19.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,873.00 |
| Dec 31, 2025 | -16,966.00 |
| Sep 30, 2025 | -6,239.00 |
| Jun 30, 2025 | -3,111.00 |
| Mar 31, 2025 | -2,349.00 |
| Dec 31, 2024 | -22,216.00 |
| Sep 30, 2024 | 61,178.00 |
| Jun 30, 2024 | -13,761.00 |
| Mar 31, 2024 | 13,133.00 |
| Dec 31, 2023 | 6,959.00 |
| Sep 30, 2023 | -1,374.00 |
| Jun 30, 2023 | -1,084.00 |
| Mar 31, 2023 | -758.00 |
| Dec 31, 2022 | 1,176.00 |
| Sep 30, 2022 | -420.00 |
| Jun 30, 2022 | -1,075.00 |
| Mar 31, 2022 | -373.00 |
| Dec 31, 2021 | -1,295.00 |
| Sep 30, 2021 | 3,946.00 |
| Jun 30, 2021 | 1,596.00 |